Ono Pharmaceutical Co Ltd 2015 Integrated Report
The report covers ONO PHARMACEUTICAL's 2014 fiscal year and combines consolidated financial results with CSR reporting. It highlights OPDIVO's approvals and launch in Japan and the U.S.A., alongside expansion of overseas subsidiaries in South Korea and Taiwan. CSR priorities include human resources and human rights, the environment, fair operating practices, and society, supported by a CSR Committee. The report also includes limited independent assurance of energy-derived CO2 emissions from domestic business locations.
Company: Ono Pharmaceutical Co Ltd
Sector: Manufacturing
Country: Japan
Year: 2015
Type: Integrated Report
Pages: 122
Back to company
Ono Pharmaceutical Co Ltd
Corporate Report
The report covers ONO PHARMACEUTICAL's 2014 fiscal year and combines consolidated financial results with CSR reporting. It highlights OPDIVO's approvals and launch in Japan and the U.S.A., alongside expansion of overseas subsidiaries in South Korea and Taiwan. CSR priorities include human resources and human rights, the environment, fair operating practices, and society, supported by a CSR Committee. The report also includes limited independent assurance of energy-derived CO2 emissions from domestic business locations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2015
Reporting Period
Apr 1, 2014 - Mar 31, 2015
Fiscal Year
2014
Published
Aug 1, 2015
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Employees